Matthew Zuga
2021
In 2021, Matthew Zuga earned a total compensation of $778.8K as Chief Financial Officer and Chief Business Officer at Acumen Pharmaceuticals.
Compensation breakdown
| Bonus | $55,000 |
|---|---|
| Non-Equity Incentive Plan | $150,921 |
| Option Awards | $257,280 |
| Salary | $315,430 |
| Other | $200 |
| Total | $778,831 |
Zuga received $315.4K in salary, accounting for 41% of the total pay in 2021.
Zuga also received $55K in bonus, $150.9K in non-equity incentive plan, $257.3K in option awards and $200 in other compensation.
Rankings
In 2021, Matthew Zuga's compensation ranked 9,570th out of 12,415 executives tracked by ExecPay. In other words, Zuga earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,570 out of 12,415 | 23rd |
Division Manufacturing | 4,244 out of 5,505 | 23rd |
Major group Chemicals And Allied Products | 1,880 out of 2,375 | 21st |
Industry group Drugs | 1,668 out of 2,096 | 20th |
Industry Biological Products, Except Diagnostic Substances | 363 out of 449 | 19th |
Source: SEC filing on April 27, 2022.
Zuga's colleagues
We found two more compensation records of executives who worked with Matthew Zuga at Acumen Pharmaceuticals in 2021.